ERG immunocytochemistry can identify prostate cancer patients prior to prostate biopsy

被引：0
|
作者：
Pal, R. P. [1 ]
Hollox, E. J. [2 ]
Cresswell, L. [3 ]
Pringle, J. H. [4 ]
Veal, C. D. [2 ]
Hew, R. [5 ]
Mellon, J. K. [4 ]
Kockelbergh, R. C. [1 ]
Barwell, J. G. [2 ]
机构：
[1] Univ Hosp Leicester NHS Trust, Dept Urol, Leicester, Leics, England
[2] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England
[3] Univ Hosp Leicester NHS Trust, Dept Cytogenet, Leicester, Leics, England
[4] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England
[5] Univ Hosp Leicester NHS Trust, Dept Pathol, Leicester, Leics, England
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E424 / U930
页数：2
相关论文
共 50 条
  • [1] Urinary ERG immunocytochemistry can identify prostate cancer patients prior to prostate biopsy
    Pal, P.
    Hollox, E. J.
    Hew, R.
    Cresswell, L.
    Pringle, J. H.
    Barwell, J. G.
    Mellon, J. K.
    Kockelbergh, R. C.
    BJU INTERNATIONAL, 2012, 109 : 27 - 27
  • [2] Urinary ERG immunocytochemistry can identify prostate cancer patients prior to prostate biopsy
    Pal, P.
    Hollox, E. J.
    Cresswell, L.
    Pringle, J. H.
    Hew, R.
    Barwell, J. G.
    Mellon, J. K.
    Kockelbergh, R. C.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 56 - 57
  • [3] ENHANCED ERG EXPRESSION ON EXON 1.0 ST ARRAYS CAN IDENTIFY TMPRSS2-ERG FUSIONS IN PROSTATE CANCER PATIENTS
    Smit, F. P.
    Salagierski, M.
    Schalken, J. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 220 - 220
  • [4] PROSTATE CANCER GENETIC VARIANTS CAN HELP IDENTIFY PATIENTS WITH POSSIBLY "INSIGNIFICANT" PROSTATE CANCER
    Helfand, Brian T.
    Loeb, Stacy
    Kan, Donghui
    Fought, Angela J.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 101 - 101
  • [5] Is MRI/US Fusion Targeted Biopsy Alone Adequate for Detecting Prostate Cancer in Patients with a Prior Negative Prostate Biopsy?
    Pena, Maria Del Carmen Rodriguez
    Eich, Marie-Lisa
    Porter, Kristin
    Glaser, Zachary
    Nix, Jeffrey
    Rais-Bahrami, Soroush
    Gordetsky, Jennifer
    LABORATORY INVESTIGATION, 2019, 99
  • [6] Is MRI/US Fusion Targeted Biopsy Alone Adequate for Detecting Prostate Cancer in Patients with a Prior Negative Prostate Biopsy?
    Pena, Maria Del Carmen Rodriguez
    Eich, Marie-Lisa
    Porter, Kristin
    Glaser, Zachary
    Nix, Jeffrey
    Rais-Bahrami, Soroush
    Gordetsky, Jennifer
    MODERN PATHOLOGY, 2019, 32
  • [7] The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy
    Schmid, Marianne
    Hansen, Jens
    Rink, Micheal
    Fisch, Margit
    Chun, Felix
    BIOMARKERS IN MEDICINE, 2013, 7 (06) : 843 - 850
  • [8] ERG and Prostein Expression in Prostate Cancer Identify Different Pathways of Progression
    Juanpere, Nuria
    Lloreta, Josep
    Font, Alba
    Lorenzo, Marta
    Albero, Raquel
    Vazquez, Ivonne
    Fumado, Lluis
    Cecchini, Lluis
    Serrano, Sergio
    Hernandez, Silvia
    MODERN PATHOLOGY, 2016, 29 : 241A - 241A
  • [9] ERG and Prostein Expression in Prostate Cancer Identify Different Pathways of Progression
    Juanpere, Nuria
    Lloreta, Josep
    Font, Alba
    Lorenzo, Marta
    Albero, Raquel
    Vazquez, Ivonne
    Fumado, Lluis
    Cecchini, Lluis
    Serrano, Sergio
    Hernandez, Silvia
    LABORATORY INVESTIGATION, 2016, 96 : 241A - 241A
  • [10] The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy
    Thompson, Ian M.
    Tangen, Catherine M.
    Ankerst, Donna P.
    Chi, Chen
    Lucia, M. Scott
    Goodman, Phyllis
    Parnes, Howard
    Coltman, Charles A., Jr.
    JOURNAL OF UROLOGY, 2008, 180 (02): : 544 - 547
12345